miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma

Oncology Reports

Volumn 27, Issue 5, 2012, Pages 1660-1668

  Zhu, Qin ^a   Wang, Zhiming ^a   Hu, Yu ^a   Li, Jindong ^a   Li, Xinying ^a   Zhou, Ledu ^a   Huang, Yun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Activation protein 1; Hepatocellular carcinoma; Invasion; microRNA 21; Migration; Programmed cell death 4

Indexed keywords

GELATINASE A; GELATINASE B; MICRORNA 21; ONCOPROTEIN; PROGRAMMED DEATH 4 PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION;

ADULT; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTIONAL ACTIVATION;

EID: 84863236989     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1682     Document Type: Article

References (37)

1. Hanazaki K, Kajikawa S, Shimozawa N, et al: Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 191: 381-388, 2000.
2. Sanefuji K, Taketomi A, Iguchi T, Sugimachi K, Ikegami T and Yamashita Y: Significance of DNA polymerase delta catalytic subunit p125 induced by mutant p53 in the invasive potential of human hepatocellular carcinoma. Oncology 79: 229-237, 2010.
3. Endo K, Ueda T, Ohta T and Terada T: Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma. Liver 20: 209-215, 2000. (Pubitemid 30342718)
4. Onishi T, Nouso K, Higashi T, Toshikuni N, Nakatsukasa H and Kobayashi Y: Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma. J Gastroenterol Hepatol 18: 1168-1174, 2003. (Pubitemid 37410047)
5. Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH and Cheng CC: Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma. J Gastrointest Surg 15: 321-329, 2011.
6. Shim JH, Park JW, Kim JH, An M and Kong SY: Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Sci 99: 2037-2044, 2008.
7. Valencia-Sanchez MA, Liu J, Hannon GJ and Parker R: Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515-524, 2006. (Pubitemid 43345317)
8. Selaru FM, Olaru AV, Kan T, David S and Cheng Y: MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 49: 1595-1601, 2009.
9. Rask L, Balslev E, Jørgensen S, Eriksen J, Flyger H and Møller S: High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 119: 663-673, 2011.
10. Lee JH, Voortman J, Dingemans AM, Voeller DM and Pham T: MicroRNA expression and clinical outcome of small cell lung cancer. PLoS One 6: 1300-1308, 2011.
11. Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM and Sañudo A: MicroRNA expression profiles in the progression of prostate cancer-from high-grade prostate intraepithelial neoplasia to metastasis. Urol Oncol 29: 101-107, 2011.
12. Cottonham CL, Kaneko S and Xu L: miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 285: 35293-35302, 2010.
13. Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336, 2007. (Pubitemid 47100416)
14. Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo YY: MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359, 2008. (Pubitemid 351333899)
15. Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D and Abdellatif M: MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19: 3272-3282, 2008.
16. Meng F, Henson R, Janek H, Ghoshal K, Jacob S and Patel T: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658, 2007. (Pubitemid 47187346)
17. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S and Allgayer H: Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 26: 4550-4562, 2007. (Pubitemid 47039134)
18. Zhang H, Ozaki I, Mizuta T and Hamajima H: Involvement of programmed cell death 4 in transforming growth factor-b1-induced apoptosis in human hepatocellular carcinoma. Oncogene 25: 6101-6112, 2006. (Pubitemid 44562408)
19. Bhatti I, Lee A, James V, Hall RI, Lund JN, Tufarelli C, et al: Knockdown of miR-21 inhibits proliferation and increases cell death by targeting PDCD4 in pancreatic ductal adenocarcinoma. J Gastrointest Surg 15: 199-208, 2011.
20. International Union Against Cancer (UICC). TNM Classification of Malignant Tumors. Sobin LH and Witterkind C (eds). 6th edition, Wiley-Liss, New York, pp81-83, 2002.
21. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: 2002-2007, 2001.
22. Lee TK, Man K, Ho JW, Wang XH, Poon TP, Xu Y, et al: FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res 11: 8458-8466, 2005. (Pubitemid 41746961)
23. Carinci F, Lo ML, Piattelli A, Rubini C, Chiesa F, Ionna F, Palmieri A, Maiorano E, Pastore A, Laino G, et al: Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol 18: 513-524, 2005. (Pubitemid 41532366)
24. Chen Y, Liu W, Chao T, Zhang Y, Yan X, et al: MicroRNA-21 downregulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G. Cancer Lett 18: 197-205, 2008.
25. Jansen AP, Camalier CE, Stark C and Colburn NH: Charac- terization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3: 103-110, 2004. (Pubitemid 39193684)
26. Nieves-Alicea R, Colburn NH, Simeone AM and Tari AM: Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res Treat 114: 203-209, 2009.
27. Bitomsky N, Bohm M and Klempnauer KH: Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493, 2004. (Pubitemid 39389690)
28. Yang HS, Matthews CP, Clair T, Wang Q, Baker AR, Li CC, Tan TH and Colburn NH: Tumorigenesis suppressor Pdcd4 downregulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol 26: 1297-1306, 2006. (Pubitemid 43202557)
29. Shaulian E and Karin M: AP-1 in cell proliferation and survival. Oncogene 20: 2390-2400, 2001. (Pubitemid 32531297)
30. Benbow U and Brinckerhoff CE: The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15: 519-526, 1997. (Pubitemid 27190026)
31. Crawford HC and Matrisian LM: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49: 20-37, 1996. (Pubitemid 26181735)
32. Curran S and Murray GI: Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36: 1621-1630, 2000. (Pubitemid 30616366)
33. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG and Parks WC: The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 137: 1445-1457, 1997. (Pubitemid 27265954)
34. Shin EY, Kim SY and Kim EG: c-Jun N-terminal kinase is involved in motility of endothelial cell. Exp Mol Med 33: 276-283, 2001.
35. Hennigan RF, Hawker KL and Ozanne BW: Fos-transformation activates genes associated with invasion. Oncogene 9: 3591-3600, 1994. (Pubitemid 24359397)
36. Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M, Bussolino F and Oliviero S: c-Fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA 96: 9671-9676, 1999. (Pubitemid 29398790)
37. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N and Sakurai K: miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 378: 492-504, 2008.